Moderna (MRNA) Confirms FDA Authorization of Booster Dose of its COVID-19 Vaccine in the U.S.

Go back to Moderna (MRNA) Confirms FDA Authorization of Booster Dose of its COVID-19 Vaccine in the U.S.

Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.

October 20, 2021 5:37 PM EDT

Emergency Use Authorization (EUA) granted for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups

FDA also authorized the use of Modernas booster dose following primary vaccination with other authorized or approved COVID-19 vaccines

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Moderna, Inc. (Nasdaq:... More